| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-10 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.18 | 5e-08 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |